Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice Chung

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activityNicholas D Smith, Steve F Poon, Dehua Huang, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2005
3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonistsLida R Tehrani, Nicholas D Smith, Dehua Huang, et al.
Journal of Medicinal Chemistry|September 3, 2004
Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activityJeffrey Roppe, Nicholas D Smith, Dehua Huang, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activityJeffrey R Roppe, Bowei Wang, Dehua Huang, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2005
Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonistsPeter C Chua, Johnny Y Nagasawa, Leo S Bleicher, et al.
Iscience|May 1, 2020
Injectable Therapeutic Organoids Using Sacrificial HydrogelsNinna S Rossen, Priya N Anandakumaran, Rafael Zur Nieden, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activityNicholas D Smith, Steve F Poon, Dehua Huang, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2005
3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonistsLida R Tehrani, Nicholas D Smith, Dehua Huang, et al.
Journal of Medicinal Chemistry|September 3, 2004
Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activityJeffrey Roppe, Nicholas D Smith, Dehua Huang, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activityJeffrey R Roppe, Bowei Wang, Dehua Huang, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2005
Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonistsPeter C Chua, Johnny Y Nagasawa, Leo S Bleicher, et al.
Iscience|May 1, 2020
Injectable Therapeutic Organoids Using Sacrificial HydrogelsNinna S Rossen, Priya N Anandakumaran, Rafael Zur Nieden, et al.
Pageof 3